Patents by Inventor Erik J. Jensen

Erik J. Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210270803
    Abstract: The present invention provides a method of identifying an animal for which antibiotic treatment, anti-infective treatment, probiotic treatment, immunostimulant treatment, additional monitoring and/or a separate or alternative management strategy is appropriate, comprising: a) collecting a sample from said animal; b) performing a leukocyte differential cell count on said sample; c) comparing said leukocyte differential cell count of (b) with an index of infection; and d) initiating antibiotic treatment, anti-infective treatment, probiotic treatment, immunostimulant treatment, additional monitoring and/or a separate or alternative management strategy of said animal on the basis of said comparing step.
    Type: Application
    Filed: February 12, 2021
    Publication date: September 2, 2021
    Inventors: Joy Parr Drach, Mitchell Hockett, Stefano Bresolin, Erik J. Jensen, Tobias M. Heineck, Jasper N. Pollard, Deborah Asion, Rodolfo R. Rodriguez, David A. Calderwood, Norah Gerow Bate, John Richard Sink, Jorge Carlos Correa
  • Patent number: 10222383
    Abstract: The present invention provides methods and compositions for detecting Mycoplasma exposure in a subject.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: March 5, 2019
    Assignee: Advanced Animal Diagnostics, Inc.
    Inventors: Robert L. Campbell, Melissa E. Langer, Jasper N. Pollard, Robert L. Cheek, Kevin G. Dolan, W. William Stewart, Stefano Bresolin, John Richard Sink, Tobias M. Heineck, Laura A. Black, Nathan F. Pope, Lauren K. Parker, Erik J. Jensen, Jorge Carlos Correa, Reha O. Azizoglu
  • Publication number: 20170276663
    Abstract: The present invention provides a method of identifying an animal for which antibiotic treatment, anti-infective treatment, probiotic treatment, immunostimulant treatment, additional monitoring and/or a separate or alternative management strategy is appropriate, comprising: a) collecting a sample from said animal; b) performing a leukocyte differential cell count on said sample; c) comparing said leukocyte differential cell count of (b) with an index of infection; and d) initiating antibiotic treatment, anti-infective treatment, probiotic treatment, immunostimulant treatment, additional monitoring and/or a separate or alternative management strategy of said animal on the basis of said comparing step.
    Type: Application
    Filed: March 22, 2017
    Publication date: September 28, 2017
    Inventors: Joy Parr Drach, Mitchell Hockett, Stefano Bresolin, Erik J. Jensen, Tobias M. Heineck, Jasper N. Pollard, Deborah Asion, Rodolfo R. Rodriguez, David A. Calderwood, Norah Gerow Bate, John Richard Sink, Jorge Carlos Correa
  • Publication number: 20170219604
    Abstract: The present invention provides methods and compositions for detecting Mycoplasma exposure in a subject.
    Type: Application
    Filed: January 27, 2017
    Publication date: August 3, 2017
    Inventors: Robert L. Campbell, Melissa E. Langer, Jasper N. Pollard, Robert L. Cheek, Kevin G. Dolan, W. William Stewart, Stefano Bresolin, John Richard Sink, Tobias M. Heineck, Laura A. Black, Nathan F. Pope, Lauren K. Parker, Erik J. Jensen, Jorge Carlos Correa, Reha O. Azizoglu